Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda
California
94502
United States
Tel: 650-837-7000
Website: http://www.exelixis.com/
842 articles about Exelixis, Inc.
-
Exelixis, Inc. Says Genentech, Inc. Exercises Option to Develop Cancer Drug
3/14/2008
-
Exelixis, Inc. Announces Full Year and Fourth Quarter 2007 Financial Results Annual Revenues Up, Net Loss Down, Cash Position Strong, as Pipeline Continues to Mature
2/15/2008
-
Exelixis, Inc. Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
2/11/2008
-
Exelixis, Inc. Announces February 12 Webcast of Presentation at the 10th Annual Biotechnology Industry Organization (BIO) CEO and Investor Conference
2/7/2008
-
Exelixis, Inc. Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
1/25/2008
-
Exelixis, Inc. and Bristol-Myers Squibb Company to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway; Exelixis will Receive $20 Million Milestone Payment and will Share U.S. Profits 50/50
1/22/2008
-
Exelixis, Inc. Says GlaxoSmithKline Does Not Option XL784 for Further Development
1/21/2008
-
Exelixis, Inc. Says Quickly Filled Spots in Cancer Trial
1/11/2008
-
Exelixis, Inc. Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
1/7/2008
-
Exelixis, Inc. Announces Senior Management Promotions
1/4/2008
-
Exelixis, Inc. Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
1/3/2008
-
Exelixis, Inc. Submits XL139 Diligence Report to Bristol-Myers Squibb
12/20/2007
-
Exelixis, Inc. Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
12/10/2007
-
Exelixis, Inc. Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society of Hematology 48th Annual Meeting
12/7/2007
-
Exelixis, Inc. Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction With The American Society of Hematology 48th Annual Meeting
12/4/2007
-
Exelixis, Inc. to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
11/29/2007
-
Exelixis, Inc. Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
11/26/2007
-
Exelixis, Inc. Announces December 5 Webcast of Its Third Annual R&D Day
11/21/2007
-
Exelixis, Inc. Sells 80% Stake in Artemis Pharmaceuticals GmBh to Taconic Farms, Inc.
11/20/2007
-
Exelixis, Inc. Announces Third Quarter 2007 Financial Results and Business Update
11/6/2007